95260 ⎘
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
OXOACRIDINYL ACETIC ACID DERIVATIVES AND METHODS OF USE
#902Quinazoline Compounds, Preparation Method, Use, and Pharmaceutical Composition Thereof
#903GPR84 ANTAGONISTS AND USES THEREOF
#904Quinazoline Compounds, Preparation Method, Use, and Pharmaceutical Composition Thereof
#905Compounds and methods for treating oxalate-related diseases
#906Substituted pyrimidines, pharmaceutical compositions and therapeutic methods thereof
#907SMALL MOLECULE INHIBITORS OF SCL15A4 WITH ANTI-INFLAMMATORY ACTIVITY
#908HETEROARYL COMPOUNDS AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF BETA-GLUCOCEREBROSIDASE
#909ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION
#910JNK INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#911COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF
#912SMARCA INHIBITORS AND USES THEREOF
#913EBNA1 inhibitor crystalline forms, and methods of preparing and using same
#914Heteroaryl compounds for kinase inhibition
#915C5AR ANTAGONISTS
#916COMPOUND AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR AND USE THEREOF
#917Therapeutics for the treatment of glaucoma
#918DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#919TRIAZOLO[4,5-D] PYRAMIDINE DERIVATIVES AND THEIR USE AS PURINE RECEPTOR ANTAGONISTS
#920MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#921Human plasma kallikrein inhibitors
#922BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF
#923Compounds and compositions for treating conditions associated with NLRP activity
#924Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction
#925AZETIDINE SULFONAMIDE COMPOUND
#926MOR RECEPTOR AGONIST COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
#927Photoactive fluorophores and methods of in vivo labeling
#928Modulators of HSD17B13 and methods of use thereof
#929Human plasma kallikrein inhibitors
#930SOLID FORMS OF TEZACAFTOR AND PROCESSES FOR THE PREPARATION THEREOF
#931COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#932GPR84 ANTAGONISTS AND USES THEREOF
#933LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS
#934Cardiac sarcomere inhibitors
#935GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
#936ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#937LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME
#938INHIBITORS OF ANOCTAMIN 6 PROTEIN AND USES THEREOF
#939GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
#940INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS
#941MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
#942SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOF
#943SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS
#944Substituted indoles and methods of use thereof
#945ROR-GAMMA-T INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF
#946NUCLEAR RECEPTOR MODULATORS
#947TRICYCLIC COMPOUNDS WITH OMA1/OPA1 MODULATORY PROPERTIES
#948PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF
#949Modulators of Mas-related G-protein receptor X2 and related products and methods
#950HETEROCYCLIC COMPOUND AND USE THEREOF
#951HEPATITIS B CAPSID ASSEMBLY MODULATORS
#952Compounds and compositions for treating conditions associated with NLRP activity
#953LIGHT-RECEIVING DEVICE AND LIGHT-EMITTING AND LIGHT-RECEIVING APPARATUS
#954CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS
#955ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE
#956NOVEL PROCESSES FOR PREPARATION OF TEZACAFTOR
#957Pyrazole-containing macrophage migration inhibitory factor inhibitors
#958Human plasma kallikrein inhibitors
#959Methods and compounds for restoring mutant p53 function
#960PYRIDAZINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS
#961Sigma ligand compounds and uses thereof
#962COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#963Inhibitors of NLRP3 inflammasome
#964NOVEL PHENOL COMPOUND OR SALT THEREOF
#965COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#966INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY
#967SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT
#968Methods and compounds for restoring mutant p53 function
#969COMPOUNDS FOR ELECTRONIC DEVICES
#970ISOQUINOLINE DERIVATIVES AS SIK2 INHIBITORS
#971Bicyclic carboxamides and methods of use thereof
#972SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME
#973Diarylamide Compound and Application Thereof
#974TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES
#975MATRIPTASE 2 INHIBITORS AND USES THEREOF
#976MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY
#977SMALL MOLECULE MODULATORS OF SIGMA-1 AND SIGMA-2 RECEPTORS AND USES THEREOF
#978AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE
#979Bicyclic compounds as androgen receptor modulators
#980Substituted indole Mcl-1 inhibitors
#981Alkene-containing amide compound and application thereof
#982ANTI-ALS COMPOUNDS
#983COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
#984NOVEL SALTS OF INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS
#985MrgprX2 Antagonists and Uses Thereof
#986ISOQUINOLINONE DERIVATIVES, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING POLY(ADP-RIBOSE) POLYMERASE-1-RELATED DISEASES, COMPRISING THE SAME AS ACTIVE INGREDIENT
#987SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF
#988TRPV4 RECEPTOR LIGANDS
#989ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
#990TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF
#991Protease inhibitors for treatment of coronavirus infections
#992COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#993NOVEL CRYSTALLINE FORM OF GPR40 AGONIST
#994COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#995Methods and compositions of inhibiting DCN1-UBC12 interaction
#996System and method of wagering on a plurality of events
#997Quinazolinones as PARP14 inhibitors
#998Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
#999PHTHALAZINONE DERIVATIVES
#1000INHIBITORS OF APOL1 AND METHODS OF USING SAME
#1001SUBSTITUTED TRICYCLIC COMPOUNDS
#1002COMPOUNDS FOR THE TREATMENT OF HIV
#1003TRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#1004Inhibitors of APOL1 and methods of using same
#10054,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases
#1006N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS
#10073-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
#1008COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#1009NOVEL COMPOUNDS AND THEIR USE AS SELECTIVE INHIBITORS OF CASPASE-2
#1010Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#1011Imino sulfanone inhibitors of ENPP1
#1012INDENE DERIVATIVES USEFUL IN TREATING PAIN AND INFLAMMATION
#1013COMPOUNDS AND USES THEREOF
#1014Arylamide derivative having antitumor activity
#1015Nitrogen-containing compounds, electronic elements and electronic devices
#1016Glycosidase inhibitors
#1017SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF
#1018SMALL MOLECULE MODULATORS OF MHC-I
#1019Modulators of ATP-binding cassette transporters
#1020Trioxolane agents
#1021Amide derivative and preparation method therefore and use thereof in medicine
#1022MODULATION OF BACTERIAL QUORUM SENSING WITH SYNTHETIC LIGANDS
#1023AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS
#1024ORGANIC ELECTROLUMINESCENT DEVICE
#1025COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
#1026Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease
#1027Hydantoin containing deoxyuridine triphosphatase inhibitors
#1028Organic photodetector and electronic device including the same
#1029COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS
#1030COMPOUNDS
#1031Anticancer compounds
#1032BAX INHIBITORS AND USES THEREOF
#1033Sulfonamide benzamide derivative and preparation method and application thereof
#1034[(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND SALTS THEREOF, CROP PROTECTION COMPOSITIONS COMPRISING THEM, METHODS FOR PRODUCING THEM AND USE THEREOF AS SAFENERS
#1035Phenyl Amino Pyrimidine Compounds and Uses Thereof
#1036MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS
#1037ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES
#1038COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#1039ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#1040Splicing modulator antibody-drug conjugates and methods of use
#1041CYCLOALKYL 3-OXOPIPERAZINE CARBOXAMIDES AND CYCLOHETEROALKYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS
#1042PTPRD inhibitors and uses thereof
#1043P2X4 receptor antagonist
#1044SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#1045SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#1046Heteroaryl compounds as kinase inhibitor
#1047P2X7R ANTAGONISTS
#1048IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY
#1049PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS
#1050Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
#1051CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATING AGENTS
#1052CRYSTALLINE FORMS OF ENTRECTINIB
#1053Cycloolefin substituted heteroaromatic compounds and their use
#1054ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1055Theramutein modulators
#1056PYRIDINIUM SALT AND PEST CONTROL AGENT
#1057LIGHT-EMITTING DEVICE AND METHOD OF MANUFACTURING THE SAME
#1058Glucose uptake inhibitors
#1059ANTIVIRAL COMPOUNDS
#1060Theramutein modulators
#1061INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#1062Aryl-n-aryl derivatives for treating a RNA virus infection
#1063PYRIDIN-2-ONE COMPOUNDS USEFUL AS SMARCA2 ANTAGONISTS
#1064Inhibtors of RAF kinases
#1065Compositions for treating neurodegenerative diseases
#1066NOVEL COMPOUNDS
#1067Substituted quinazolines for inhibiting kinase activity
#1068Therapeutically active compounds and their methods of use
#1069ORGANIC LIGHT EMITTING DEVICE
#1070CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF
#1071Benzoimidazole Derivatives As Anticancer Agents
#1072Therapeutically active compounds and their methods of use
#1073ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1074HETEROCYLIC COMPOUND AND LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE HETEROCYCLIC COMPOUND
#1075CANNABINOID DERIVATIVES
#1076HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS
#1077CRYSTALLINE FORM OF CXCR2 ANTAGONIST AND APPLICATION THEREOF
#1078INHIBITORS OF SARM1
#1079Inhibitors of APOL1 and methods of using same
#1080Organic compound, electronic element, and electronic device
#1081Imidazole-containing inhibitors of ALK2 kinase
#1082PERK INHIBITING COMPOUNDS
#1083Compounds and compositions for use in treating skin disorders
#1084ANTIMALARIAL AGENTS
#1085Antagonists of T2R54 and compositions and uses thereof
#1086NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF
#1087COMPOUNDS SUITABLE FOR THE TREATMENT AND PROPHYLAXIS OF MUSCLE WASTING AND OTHER CONDITIONS
#1088Dantrolene prodrugs and methods of their use
#1089TRUNCATED ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF
#1090ANTIBACTERIAL COMPOUNDS
#1091CANCER TREATMENTS TARGETING CANCER STEM CELLS
#1092QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
#1093HETEROARYLAMIDOPYRIDINOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE
#1094Inhibitors of NLRP3 inflammasome
#10951,3-substituted cyclobutyl derivatives and uses thereof
#1096SARS-3CL PROTEASE INHIBITORS
#1097Organic light emitting device and display apparatus
#1098LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND
#1099Bromodomain inhibitors
#1100Substituted guanidine compounds
#1101Substituted Ureas and Methods of Making and Using Same
#1102Methods of treating cancer
#1103Methods and compounds for restoring mutant p53 function
#1104INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF
#1105USP30 inhibitors and uses thereof
#1106NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) INHIBITOR-CONJUGATES AND USES THEREOF
#1107Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
#1108Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors
#1109BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#11105-hydroxytryptamine receptor 7 activity modulators and their method of use
#1111Triazine derivatives for treating diseases relating to neurotrophins
#1112TETRACYCLIC COMPOUND
#1113Nitrogen-containing compound, electronic element and electronic device
#1114Neprilysin inhibitors
#1115Compounds, salts thereof and methods for treatment of diseases
#1116ENZYME INHIBITORS
#1117ORGANIC ELECTRONIC DEVICE
#1118Hepatitis B capsid assembly modulators
#1119Heterocyclic modulators of lipid synthesis
#1120LIGHT-EMITTING DEVICE INCLUDING AMINE-BASED COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE AMINE-BASED COMPOUND
#1121Dihydrobenzimidazolones for medical treatment
#1122KIF18A INHIBITORS
#1123SUBSTITUTED N-PHENYL URACILS, SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS
#1124INHIBITORS OF HUMAN ATGL
#11255-AMINO-SUBSTITUTED PYRAZOLES AND TRIAZOLES AS PEST CONTROL AGENTS
#1126HETEROCYCLIC COMPOUND
#1127Compounds for the treatment of BRAF-associated diseases and disorders
#1128AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME
#1129Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same
#1130COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#1131COMBINATION THERAPY FOR TREATING CANCER
#1132Bisamide sarcomere activating compounds and uses thereof
#1133SUBSTITUTED PIPERAZINES AS SELECTIVE HDAC1,2 INHIBITORS
#1134LIGHT-EMITTING DEVICE INCLUDING FUSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE FUSED CYCLIC COMPOUND
#1135Compositions and Methods of Using the Same for Treatment of Neurodegenerative and Mitochondrial Disease
#1136ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC INFECTIONS
#1137PROTECTED TRIAZABUTADIENE COMPOSITIONS FOR CELLULAR STUDIES IN INTACT BIOLOGICAL SYSTEMS
#1138PAPD5 INHIBITORS AND METHODS OF USE THEREOF
#1139CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY
#1140MICROBIOCIDAL DERIVATIVES
#1141SULFONAMIDE DERIVATIVES AND USES THEREOF
#1142COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS
#1143HETEROCYCLIC IMMUNOMODULATORS AS PDL1 CHECKPOINT INHIBITOR
#1144PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME
#1145FUROSEMIDE ANALOGUES AND COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ALZHEIMER'S DISEASE
#1146ANTIBACTERIAL AND ANTIPARASITIC QUINOXALINE-2,3-DIAMINE DERIVATIVES
#1147Targeted Nitroxide Compounds and Their Use in Treating Ferroptosis-Related Diseases
#1148SARS-COV-2 MAIN PROTEASE INHIBITORS
#1149Catecholamine prodrugs for use in the treatment of parkinson's disease
#1150Aromatic amine derivatives and organic electroluminescent elements using same
#1151Inhibitors of Beta-Hydoxylase for Treatment of Cancer
#1152Tead inhibitors and uses thereof
#1153HETEROCYCLIC INHIBITORS OF MCT4
#1154MCT4 inhibitors for treating disease
#1155PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY
#1156Small molecule inducers of autophagy
#1157METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS
#11582-METHYL-QUINAZOLINES
#1159NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)
#1160Compositions and methods for inhibiting IDO1
#1161HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#1162GPR40 AGONISTS
#1163ACYL SULFONAMIDES FOR TREATING CANCER
#1164Compositions and methods for viral sensitization
#1165Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1
#1166NEW CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
#1167Aminopyrazine diol compounds as PI3K-γ inhibitors
#1168METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
#1169HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
#1170Pyridinium salts and pest control agent
#1171Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#1172NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME
#1173ARYLSULFONYLTHIOPHENECARBOXAMIDES AND ARYLSULFONYLFURANCARBOXAMIDES AS Kv3 POTASSIUM CHANNEL ACTIVATORS
#1174Novel Substituted N-(3-Fluoropropyl)-Pyrrolidine Compounds, Processes for their Preparation and Therapeutic Uses Thereof
#1175Stabilization of amyloidogenic immunoglobulin light chains
#1176CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBXO7 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA
#1177RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF
#1178Compounds and methods for treating autoimmune disorders by targeting HLA-DQ2
#1179Light-emitting diode and amine compound for the same
#1180NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE
#1181PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#1182LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME
#1183Methods and systems for wireless to power line communications
#1184PHARMACEUTICAL COMPOUNDS AND THERAPEUTIC METHODS
#1185Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
#1186HBV inhibitor and its use
#1187Sulfoximine glycosidase inhibitors
#1188SMALL MOLECULES THAT BIND CYCLIN-DEPENDENT KINASE INHIBITOR 1B (P27KIP1)
#1189COMPOUNDS, COMPOSITIONS AND METHODS
#1190Modulators of mas-related G-protein receptor X2 and related products and methods
#1191Opioid receptor ligands and methods of using and making same
#1192N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
#1193METHODS AND MATERIALS FOR INCREASING OR MAINTAINING NICOTINAMIDE MONONUCLEOTIDE ADENYLYL TRANSFERASE-2 (NMNAT2) POLYPEPTIDE LEVELS
#1194Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#1195ANTIBODY DRUG CONJUGATES
#1196Herbicidal compounds
#1197COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND OXIDATIVE METABOLISM
#1198MYST family histone acetyltransferase inhibitors
#1199Picolinamide compounds with fungicidal activity
#1200Materials for electronic devices